Hepatitis E virus is the leading cause of acute viral hepatitis in Lothian, Scotland

New Microbes and New Infections

Volumn 10, Issue , 2016, Pages 6-12

  Kokki, I ^a   Smith, D ^b   Simmonds, P ^c   Ramalingam, S ^a   Wellington, L ^d   Willocks, L ^d   Johannessen, I ^a   Harvala, H ^a,e,f  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NHS LOTHIAN   (United Kingdom)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Clinical virology; Edinburgh; Public health; RNA virus; Virus diagnostic

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ADULT; ARTICLE; BIOASSAY; BLOOD SAMPLING; ETHNICITY; FEMALE; GENDER; GENE SEQUENCE; GENOTYPE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; JAUNDICE; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PORK; PRIORITY JOURNAL; RECOMWELL ASSAY; RETROSPECTIVE STUDY; RISK FACTOR; RNA EXTRACTION; TRAVEL; UNITED KINGDOM; UNPROTECTED SEX; VIRUS HEPATITIS; VOMITING;

EID: 84954240582     PISSN: 20522975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmni.2015.12.001     Document Type: Article

References (25)

1. Scobie L., Dalton H.R. Hepatitis E: source and route of infection, clinical manifestations and new developments. J Viral Hepat 2013, 20:1-11.
2. Emerson S.U., Purcell R.H. Hepatitis E virus. Rev Med Virol 2003, 13:145-154.
3. Huzly D., Umhau M., Bettinger D., Cathomen T., Emmerich F., Hasselblatt P., et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill 2014, 19(21).
4. Harvala H., Wong V., Simmonds P., Johannessen I., Ramalingam S. Acute viral hepatitis-should the current screening strategy be modified?. J Clin Virol 2014, 59:184-187.
5. Coudray-Meunier C., Fraisse A., Mokhtari C., Martin-Latil S., Roque-Afonso A.M., Perelle S. Hepatitis A virus subgenotyping based on RT-qPCR assay. BMC Microbiol 2014, 14:296.
6. Garson J., Ferns R., Grant P., Ijaz S., Nastouli E., Szypulska R., et al. Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results. J Virol Methods 2012, 186:157-160.
7. Ijaz S., Said B., Boxall E., Smit E., Morgan D., Tedder R.S. Indigenous hepatitis E in England and Wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses. J Infect Dis 2014, 209:1212-1218.
8. Hewitt P.E., Ijaz S., Brailsford S.R., Brett R., Dicks S., Haywood B., et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014, 384(9956):1766-1773.
9. Ramalingam S., Smith D., Wellington L., Vanek J., Simmonds P., MacGilchrist A., et al. Autochthonous hepatitis E in Scotland. J Clin Virol 2013, 58:619-623.
10. Borgen K., Herremans T., Duizer E., Vennema H., Rutjes S., Bosman A., et al. Non-travel related hepatitis E virus genotype 3 infections in the Netherlands: a case series, 2004-2006. BMC Infect Dis 2008, 8:61.
11. Drobeniuc J., Greene-Montfort T., Le N.T., Mixson-Hayden R.T., Ganova-Raeva L., Dong C., et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013, 19:218-222.
12. Peron J.M., Mansuy J.M., Poirson H., Bureau C., Dupuis E., Alric L., et al. Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in south-west France over a 13-month period and comparison with hepatitis A. Gastroenterol Clin Biol 2006, 30:757-762.
13. Riezebos-Brilman A., Verschuuren E.A., van Son W.J., van Imhoff G.W., Brügemann J., Blokzijl H., et al. The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. J Clin Virol 2013, 58:509-514.
14. Kamar N., Dalton H.R., Abravanel F., Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014, 27:116-138.
15. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013, 10:24-33.
16. Arends J.E., Ghisetti V., Irving W., Dalton H.R., Izopet J., Hoepelman A.I., et al. Hepatitis E: an emerging infection in high income countries. J Clin Virol 2014, 59:81-88.
17. Al-Shukri I., Davidson E., Tan A., Smith D., Wellington L., Johannessen I., et al. Rash and arthralgia caused by hepatitis E. Lancet 2013, 382(9907):1856.
18. Aggarwal R., Kini D., Sofat S., Naik S.R., Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000, 356:1081-1082.
19. Lockwood G.L., Fernandez-Barredo S., Bendall R., Banks M., Ijaz S., Dalton H.R. Hepatitis E autochthonous infection in chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20:800-803.
20. Peron J.M., Bureau C., Poirson H., Mansuy J.M., Alric L., Selves J., et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007, 14:298-303.
21. Kamar N., Izopet J., Tripon S., Bismuth M., Hillaire S., Dumortier J., et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014, 370:1111-1120.
22. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011, 52:60-62.
23. Robbins A., Lambert D., Ehrhard F., Brodard V., Hentzien M., Lebrun D., et al. Severe acute hepatitis E in an HIV infected patient: successful treatment with ribavirin. J Clin Virol 2014, 60:422-423.
24. Matsuda H., Okada K., Takahashi K., Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis 2003, 188:944.
25. Cleland A., Smith L., Crossan C., Blatchford O., Dalton H.R., Scobie L., et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013, 105:283-289.